| JYSB1800189 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | | Certificate Issued | 2019-02-02 | view |
| JYSZ1600015 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2016-05-10 | | | Certificate Issued | 2017-04-19 | view |
| JYSB1800050 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-23 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
| CYSB2200011 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
| JYSB1900275 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-28 | | | Certificate Issued | 2019-10-28 | view |
| JYSB1800221 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-10-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2018-12-17 | view |
| JYSB1800112 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | | Filed | 2018-05-30 | view |
| JYSB2200143 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
| JYSZ1700006 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2017-03-06 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd | Certificate Issued | 2018-07-18 | view |
| JYSB2101028 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-05-12 | | Bayer Healthcare LLC | | | view |
| CYSB2400087 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-04-09 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| JYSB1900286 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-11-22 | | | Certificate Issued | 2020-01-03 | view |
| JXSS1900042 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-07-10 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2021-01-05 | view |
| JYSB1700201 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-11-20 | | Bayer Healthcare LLC | Certificate Issued | 2018-01-16 | view |
| CYSB2200010 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
| CXSS2000021 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2020-05-29 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2021-11-05 | view |
| JYSB2200065 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
| JYSB1800202 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-29 | | | Certificate Issued | 2019-06-04 | view |
| JYSB1800056 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-28 | | | Filed | 2018-04-13 | view |
| JYSB1600273 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-01-03 | | | Certificate Issued | 2017-04-10 | view |
